Clinical Trials Browser

Completed × Rosuvastatin Calcium × Clear all

NCT07088913 2026-03-03

A Study to Investigate the Effect of Capivasertib on the Pharmacokinetics of Oral Rosuvastatin in Healthy Participants

Phase 1 Completed

20 enrolled

Healthy Participants

NCT07235748 2026-02-17

Drug-drug Interaction Study of Vorasidenib With Bupropion, Repaglinide, Flurbiprofen, Omeprazole, Midazolam, and Rosuvastatin in Healthy Adult Participants

Phase 1 Completed

28 enrolled

Healthy Adult Participants

NCT05741372 2026-01-13

A Study to Compare How Different Medicines (Rosuvastatin, Digoxin, Metformin, and Furosemide) Are Handled by the Body of Healthy People and People With Liver Cirrhosis

Phase NA Completed

28 enrolled 15 charts

Liver Cirrhosis

NCT03532139 2025-01-23

Pilot Study of Rosuvastatin and Enoxaparin Thromboprophylaxis Following Ovarian Cancer Surgery (O-STAT Study)

Phase 2 Completed

24 enrolled

Gynecologic

Ovarian Neoplasms

NCT06677957 2025-01-03

A Clinical Trial to Investigate the Clinical Drug-Drug Interaction of Divarasib With Probe Substrates of P-Glycoprotein and Breast Cancer Resistance Protein in Healthy Participants

Phase 1 Completed

19 enrolled

Healthy Participants

NCT05926180 2024-12-13

Assessing the Effect of DZD9008 on the Pharmacokinetics of the Cocktail Probes Representative for CYP3A4, P-gp, BCRP and OATP1B1 in Patients with EGFR or HER2 Mutant Advanced Non-small Cell Lung Cancer (WU-KONG19)

Phase 1 Completed

25 enrolled

Thoracic

Carcinoma, Non-Small-Cell Lung

NCT04094519 2024-11-20

A Study to Evaluate the Effect of Multiple Doses of Enzalutamide on the Pharmacokinetics of Substrates of P-glycoprotein (Digoxin) and Breast Cancer Resistant Protein (Rosuvastatin) in Male Subjects With Prostate Cancer

Phase 1 Completed

24 enrolled

Genitourinary

Prostatic Neoplasms

NCT04887194 2024-05-08

PK Study to Assess Drug-drug Interaction and QTc Between Sitravatinib and a Cocktail of Substrates

Phase 1 Completed

40 enrolled

Other solid neoplasm

Advanced Solid Tumor

NCT05338723 2024-02-28

Possible Protective Effect of Rosuvastatin in Chemotherapy-induced Cardiotoxicity in HER2 Positive Breast Cancer Patients

Phase 3 Completed

50 enrolled

Breast

Breast Neoplasms

NCT05395117 2023-12-13

A Study to Assess the Effect of AZD5462 on the Pharmacokinetics of Midazolam, Rosuvastatin and Digoxin

Phase 1 Completed

32 enrolled

Healthy Participants

NCT05045638 2023-08-14

Effect of Coadministration of Sotorasib on the Pharmacokinetics of Rosuvastatin in Healthy Participants

Phase 1 Completed

13 enrolled 14 charts

Healthy Participants

NCT04889287 2023-08-09

A Study to Learn How Much Rosuvastatin Gets Into the Blood When Taken With or Without Elinzanetant and to Learn About the Safety of Elinzanetant in Healthy Participants

Phase 1 Completed

16 enrolled

Endocrine

Multiple Endocrine Neoplasia Type 1

NCT03954366 2023-06-08

Drug-Drug Interaction Study of Rucaparib, Rosuvastatin and Oral Contraceptives

Phase 1 Completed

36 enrolled

Tumor-Agnostic

Neoplasms

NCT05708573 2023-04-14

Potential Drug Interaction Between ALXN2040 and Rosuvastatin

Phase 1 Completed

20 enrolled

Healthy Participants

NCT05368805 2022-10-06

Fruquintinib DDI Study With P-gp and BCRP Substrates

Phase 1 Completed

32 enrolled

Gastrointestinal

Colorectal Neoplasms

NCT02569645 2022-07-20

Rosuvastatin in the Treatment of Rectal Cancer

Phase 2 Completed

45 enrolled

Gastrointestinal

Rectal Neoplasms

NCT04252300 2021-03-11

Study to Learn the Effect of Drug BAY1817080 on the Way the Body Absorbs, Distributes and Excretes Another Drug Rosuvastatin in Healthy Adult Participants

Phase 1 Completed

14 enrolled

Chronic Cough, Pain

NCT04776889 2021-03-02

The Prognosis of Lipid Reprogramming With Rosuvastatin, in Castrated Egyptian Prostate Cancer Patients

Phase 4 Completed

70 enrolled

Genitourinary

Prostatic Neoplasms, Hypoalphalipoproteinemias

NCT02626234 2020-12-10

A Drug-drug Interaction (DDI) Study to Assess the Effect of INC280 on the Pharmacokinetics of Digoxin and Rosuvastatin in Patients With cMET-dysregulated Advanced Solid Tumors

Phase 1 Completed

32 enrolled

Other solid neoplasm

cMET-dysregulated Advanced Solid Tumors

NCT00966472 2020-04-21

Phase I Study of a Statin + Erlotinib for Advanced Solid Malignancies With Focus on Squamous Cell Carcinomas and NSCLC

Phase 1 Completed

24 enrolled

Thoracic

Carcinoma, Non-Small-Cell Lung, Carcinoma, Squamous Cell

NCT02106845 2019-06-07

Effect of Regorafenib on Digoxin and Rosuvastatin in Patients With Advanced Solid Malignant Tumors.

Phase 1 Completed

42 enrolled

Tumor-Agnostic

Neoplasms

NCT02317016 2018-07-31

Study to Assess the Effect of AZD9291 on the Blood Levels of Rosuvastatin, in Patients With EGFRm+ Non-small Cell Lung Cancer

Phase 1 Completed

44 enrolled 20 charts

Thoracic

Carcinoma, Non-Small-Cell Lung, Neoplasms

NCT01524653 2018-07-10

DISOLVE

Phase 2 Completed

38 enrolled

Classical hematology

Neoplasm Metastasis, Neoplasms, Venous Thrombosis, Venous Thromboembolism

NCT02671097 2016-09-08

Drug-drug Interaction Study Using Rosuvastatin as a Breast Cancer Resistant Protein (Efflux Transporter), Organic Anion-transporting Polypeptide (OATP)1B1, and OATP1B3 (Uptake Transporters) Probe Substrate

Phase 1 Completed

30 enrolled

Healthy Volunteers

NCT02300363 2015-07-09

DDI Study With Multiple-dose LX4211 and Single Dose Rosuvastatin

Phase 1 Completed

24 enrolled

Healthy